The incidence of postoperative venous thrombosis among patients with ulcerative colitis

Irish Journal of Medical Science

Volumn 174, Issue 3, 2005, Pages 20-22

  O'Connor, O J ^a   Cahill, R A ^a   Kirwan, W O ^a   Redmond, H P ^a  

^a University College Cork   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; TINZAPARIN; WARFARIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COLON POLYPOSIS; COLON RESECTION; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DOSE RESPONSE; FEMALE; HUMAN; ILEOSTOMY; INCIDENCE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PELVIS SURGERY; PERIOPERATIVE PERIOD; POSTOPERATIVE THROMBOSIS; RECTUM RESECTION; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; ULCERATIVE COLITIS;

EID: 27844556872     PISSN: 00211265     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03169142     Document Type: Article

References (11)

1. Miehsler W, Reinisch W, Valic E et al. Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut 2004; 53(4): 542-8
2. Bernstein CN, Blanchard JF, Houstan DS, Wajda A. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population based cohort study. Thromb Haemost 2001; 85(3): 430-4
3. Liebman HA, Kashan N, Sutherland D, Mcgehee W, Kann AL. The factor V Leiden mutation increases the risk of venous thrombosis in patients with inflammatory bowel disease. Gastroenterol 1998; 115(4): 830-4
4. Jackson LM, O'Gorman PJ, O'Connell J, Cronin CC, Cotter KP, Shanahan F. Thrombosis in inflammatory bowel disease: clinical setting, procoagulant profile and Factor V Leiden. Q J Med 1997; 90: 183-188
5. Faioni EM, Ferrero S, Fontana G et al. Expression of endothelial protein C receptor and thrombomodulin in the intestinal tissue of patients with inflammatory bowel disease. Crit Care Med 2004; 32(5 Suppl): S266-70
6. Talbot RW, Heppell J, Dozois RR, Beart RW Jr. Vascular complications of inflammatory bowel disease. Mayo Clin Proc 1986;61(2):140-5
7. Danese S, Motte L, Fiocchi C. Platelets in inflammatory bowel disease: clinical, pathogenic, and therapeutic implications. Am J Gastroenterol 2004; 99(5): 938-45
8. Novacek G, Miehsler W, Kapiotis S, Katzenschlager R, Speiser W, Vogelsang H. Thromboembolism and resistance to activated protein C in patients with inflammatory bowel disease. Am J Gastroenterol 1999; 94(3): 685-90
9. Aichbichler BW, Petritsch W, Reicht GA et al. Anti-cardiolipin antibodies in patients with inflammatory bowel disease. Dig Dis Sci 1999; 44(4): 852-6
10. Vecchi M, Sacchi E, Saibeni S et al. Inflammatory bowel diseases are not associated with major hereditary conditions predisposing to thrombosis. Dig Dis Sci 2000; 45(7):1465-9
11. Colditz G, Oster G, Tuden RL. Rates of venous thrombosis after general surgery: Combined results of randomised clinical trials. Lancet 1986; 19: 143-146